HAEMATOLOGICA:TGFβ 信号改变急性免疫反应的记忆导致骨髓衰竭

2021-11-03 MedSci原创 MedSci原创

慢性增加的TGFβ信号改变了急性免疫反应的记忆,导致骨髓衰竭,而不需要预先存在的遗传损伤。因此,非遗传因素的结合足以导致骨髓衰竭

针对三系细胞情况都低下异常的情况,多见于骨髓衰竭性疾病(BMF),可以分为先天性和获得性两种,而获得性BMF又分为原发性和继发性,其中常见的疾病就是再生障碍性贫血(AA)。骨髓衰竭综合征(BMF)的特征是由于造血干细胞(HSC)的适应度受损而导致造血功能失效BMF 可以在骨髓应激期间获得,或者与驱动基因突变有关。BMF 发生继发性肿瘤的风险更高,包括骨髓增生异常综合征和白血病。

尽管发现了遗传驱动突变,但该疾病的造血表现是相当异质性的,这提高了非遗传因素参与该疾病发病机制的可能性炎症的作用已成为一个重要的促成因素,但仍有待进一步了解。

 

因此,在一项研究中,一研究团队检测了TGFβ信号通路的增加在没有基因突变的情况下与急性先天免疫攻击联合使用多肌苷多胞二酸(pIC)对造血系统的影响

将转基因Tg-b1glo+/Flox小鼠与Mx1-Cre小鼠杂交,生成MxCre+;Tg-b1glo+/Flox(TgCre+)和MxCre−;Tg-b1glo+/Flox小鼠(TgCre-)。每隔一天注射3次10mg/kg/小鼠聚肌苷:聚胞苷酸(pIC,GEHealthcarce)诱导Cre重组酶表达。对小鼠外周血染色行流式细胞术,进行骨髓和脾脏的组织学检查、RNA测序、免疫荧光测定,使用小鼠TGF-beta1DuoSetELISA试剂盒和DuoSetELISA辅助试剂试剂盒对骨髓液中的活性TGFβ1进行评估。

图1:活跃的TGFβ1过表达小鼠在稳定状态的造血过程中不会出现明显的造血表型。

图2:过表达活性TGFβ1的小鼠在急性pIC应激后发生无效的造血功能和细胞发育不良。

图3:激活的tgf β1过表达SLAM造血干细胞在急性pIC胁迫后的长期表现出独特的转录特征。

图4:经过tgf β1过表达的SLAM造血干细胞在急性pIC应激后长期显示持续的线粒体活性和caspase-1活性。

研究发现,急性轮pIC单独驱动良性的与年龄相关的骨髓细胞扩张,TGFβ信号单独增加导致老年小鼠轻度贫血。与此形成鲜明对比的是,应激后的3-4个月,TGFβ信号通路增加,加上急性pIC激发导致慢性全血细胞减少,扩大造血干和祖细胞池,增加骨髓发育不良,表型类似于人类骨髓衰竭综合征。在机制上,这种疾病表型与线粒体含量的增加、活性氧的增加和caspase-1活性的增强唯一相关。

综上所述,研究的结果表明,慢性增加的TGFβ信号改变了急性免疫反应的记忆,导致骨髓衰竭而不需要预先存在的遗传损伤。因此,非遗传因素的结合足以导致骨髓衰竭。

 

原始出处:

Javier J,Hinge A,Bartram J,et al.TGFβ signaling modifies hematopoietic acute inflammatory response to drive bone marrow failure.[J].Haematologica,1970,:.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1929075, encodeId=501919290e567, content=<a href='/topic/show?id=23871020105f' target=_blank style='color:#2F92EE;'>#骨髓衰竭#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102010, encryptionId=23871020105f, topicName=骨髓衰竭)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a885259, createdName=yourmama, createdTime=Sat Mar 26 21:09:59 CST 2022, time=2022-03-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2008537, encodeId=cb03200853ed9, content=<a href='/topic/show?id=1066844469' target=_blank style='color:#2F92EE;'>#HAE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8444, encryptionId=1066844469, topicName=HAE)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=32d177, createdName=changfy, createdTime=Sat Feb 26 17:09:59 CST 2022, time=2022-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2035915, encodeId=39242035915c0, content=<a href='/topic/show?id=575c1e341a8' target=_blank style='color:#2F92EE;'>#TGF#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17341, encryptionId=575c1e341a8, topicName=TGF)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=56ea361, createdName=changhe713, createdTime=Wed Nov 03 05:09:59 CST 2021, time=2021-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2035820, encodeId=054c203582021, content=<a href='/topic/show?id=3b891e356fc' target=_blank style='color:#2F92EE;'>#TGFβ#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17356, encryptionId=3b891e356fc, topicName=TGFβ)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=467c360, createdName=yuanming7, createdTime=Tue Nov 23 09:09:59 CST 2021, time=2021-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1280255, encodeId=91f21280255df, content=<a href='/topic/show?id=2bbe289846f' target=_blank style='color:#2F92EE;'>#免疫反应#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28984, encryptionId=2bbe289846f, topicName=免疫反应)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=827b160, createdName=cnxcy, createdTime=Tue Nov 02 12:09:59 CST 2021, time=2021-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1317665, encodeId=4a6b131e6658c, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6704, encryptionId=74916e0414, topicName=EMA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a35a460, createdName=fengyi812, createdTime=Tue Nov 02 12:09:59 CST 2021, time=2021-11-02, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1929075, encodeId=501919290e567, content=<a href='/topic/show?id=23871020105f' target=_blank style='color:#2F92EE;'>#骨髓衰竭#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102010, encryptionId=23871020105f, topicName=骨髓衰竭)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a885259, createdName=yourmama, createdTime=Sat Mar 26 21:09:59 CST 2022, time=2022-03-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2008537, encodeId=cb03200853ed9, content=<a href='/topic/show?id=1066844469' target=_blank style='color:#2F92EE;'>#HAE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8444, encryptionId=1066844469, topicName=HAE)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=32d177, createdName=changfy, createdTime=Sat Feb 26 17:09:59 CST 2022, time=2022-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2035915, encodeId=39242035915c0, content=<a href='/topic/show?id=575c1e341a8' target=_blank style='color:#2F92EE;'>#TGF#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17341, encryptionId=575c1e341a8, topicName=TGF)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=56ea361, createdName=changhe713, createdTime=Wed Nov 03 05:09:59 CST 2021, time=2021-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2035820, encodeId=054c203582021, content=<a href='/topic/show?id=3b891e356fc' target=_blank style='color:#2F92EE;'>#TGFβ#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17356, encryptionId=3b891e356fc, topicName=TGFβ)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=467c360, createdName=yuanming7, createdTime=Tue Nov 23 09:09:59 CST 2021, time=2021-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1280255, encodeId=91f21280255df, content=<a href='/topic/show?id=2bbe289846f' target=_blank style='color:#2F92EE;'>#免疫反应#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28984, encryptionId=2bbe289846f, topicName=免疫反应)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=827b160, createdName=cnxcy, createdTime=Tue Nov 02 12:09:59 CST 2021, time=2021-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1317665, encodeId=4a6b131e6658c, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6704, encryptionId=74916e0414, topicName=EMA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a35a460, createdName=fengyi812, createdTime=Tue Nov 02 12:09:59 CST 2021, time=2021-11-02, status=1, ipAttribution=)]
    2022-02-26 changfy
  3. [GetPortalCommentsPageByObjectIdResponse(id=1929075, encodeId=501919290e567, content=<a href='/topic/show?id=23871020105f' target=_blank style='color:#2F92EE;'>#骨髓衰竭#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102010, encryptionId=23871020105f, topicName=骨髓衰竭)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a885259, createdName=yourmama, createdTime=Sat Mar 26 21:09:59 CST 2022, time=2022-03-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2008537, encodeId=cb03200853ed9, content=<a href='/topic/show?id=1066844469' target=_blank style='color:#2F92EE;'>#HAE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8444, encryptionId=1066844469, topicName=HAE)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=32d177, createdName=changfy, createdTime=Sat Feb 26 17:09:59 CST 2022, time=2022-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2035915, encodeId=39242035915c0, content=<a href='/topic/show?id=575c1e341a8' target=_blank style='color:#2F92EE;'>#TGF#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17341, encryptionId=575c1e341a8, topicName=TGF)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=56ea361, createdName=changhe713, createdTime=Wed Nov 03 05:09:59 CST 2021, time=2021-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2035820, encodeId=054c203582021, content=<a href='/topic/show?id=3b891e356fc' target=_blank style='color:#2F92EE;'>#TGFβ#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17356, encryptionId=3b891e356fc, topicName=TGFβ)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=467c360, createdName=yuanming7, createdTime=Tue Nov 23 09:09:59 CST 2021, time=2021-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1280255, encodeId=91f21280255df, content=<a href='/topic/show?id=2bbe289846f' target=_blank style='color:#2F92EE;'>#免疫反应#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28984, encryptionId=2bbe289846f, topicName=免疫反应)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=827b160, createdName=cnxcy, createdTime=Tue Nov 02 12:09:59 CST 2021, time=2021-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1317665, encodeId=4a6b131e6658c, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6704, encryptionId=74916e0414, topicName=EMA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a35a460, createdName=fengyi812, createdTime=Tue Nov 02 12:09:59 CST 2021, time=2021-11-02, status=1, ipAttribution=)]
    2021-11-03 changhe713
  4. [GetPortalCommentsPageByObjectIdResponse(id=1929075, encodeId=501919290e567, content=<a href='/topic/show?id=23871020105f' target=_blank style='color:#2F92EE;'>#骨髓衰竭#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102010, encryptionId=23871020105f, topicName=骨髓衰竭)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a885259, createdName=yourmama, createdTime=Sat Mar 26 21:09:59 CST 2022, time=2022-03-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2008537, encodeId=cb03200853ed9, content=<a href='/topic/show?id=1066844469' target=_blank style='color:#2F92EE;'>#HAE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8444, encryptionId=1066844469, topicName=HAE)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=32d177, createdName=changfy, createdTime=Sat Feb 26 17:09:59 CST 2022, time=2022-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2035915, encodeId=39242035915c0, content=<a href='/topic/show?id=575c1e341a8' target=_blank style='color:#2F92EE;'>#TGF#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17341, encryptionId=575c1e341a8, topicName=TGF)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=56ea361, createdName=changhe713, createdTime=Wed Nov 03 05:09:59 CST 2021, time=2021-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2035820, encodeId=054c203582021, content=<a href='/topic/show?id=3b891e356fc' target=_blank style='color:#2F92EE;'>#TGFβ#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17356, encryptionId=3b891e356fc, topicName=TGFβ)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=467c360, createdName=yuanming7, createdTime=Tue Nov 23 09:09:59 CST 2021, time=2021-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1280255, encodeId=91f21280255df, content=<a href='/topic/show?id=2bbe289846f' target=_blank style='color:#2F92EE;'>#免疫反应#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28984, encryptionId=2bbe289846f, topicName=免疫反应)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=827b160, createdName=cnxcy, createdTime=Tue Nov 02 12:09:59 CST 2021, time=2021-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1317665, encodeId=4a6b131e6658c, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6704, encryptionId=74916e0414, topicName=EMA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a35a460, createdName=fengyi812, createdTime=Tue Nov 02 12:09:59 CST 2021, time=2021-11-02, status=1, ipAttribution=)]
    2021-11-23 yuanming7
  5. [GetPortalCommentsPageByObjectIdResponse(id=1929075, encodeId=501919290e567, content=<a href='/topic/show?id=23871020105f' target=_blank style='color:#2F92EE;'>#骨髓衰竭#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102010, encryptionId=23871020105f, topicName=骨髓衰竭)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a885259, createdName=yourmama, createdTime=Sat Mar 26 21:09:59 CST 2022, time=2022-03-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2008537, encodeId=cb03200853ed9, content=<a href='/topic/show?id=1066844469' target=_blank style='color:#2F92EE;'>#HAE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8444, encryptionId=1066844469, topicName=HAE)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=32d177, createdName=changfy, createdTime=Sat Feb 26 17:09:59 CST 2022, time=2022-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2035915, encodeId=39242035915c0, content=<a href='/topic/show?id=575c1e341a8' target=_blank style='color:#2F92EE;'>#TGF#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17341, encryptionId=575c1e341a8, topicName=TGF)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=56ea361, createdName=changhe713, createdTime=Wed Nov 03 05:09:59 CST 2021, time=2021-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2035820, encodeId=054c203582021, content=<a href='/topic/show?id=3b891e356fc' target=_blank style='color:#2F92EE;'>#TGFβ#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17356, encryptionId=3b891e356fc, topicName=TGFβ)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=467c360, createdName=yuanming7, createdTime=Tue Nov 23 09:09:59 CST 2021, time=2021-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1280255, encodeId=91f21280255df, content=<a href='/topic/show?id=2bbe289846f' target=_blank style='color:#2F92EE;'>#免疫反应#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28984, encryptionId=2bbe289846f, topicName=免疫反应)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=827b160, createdName=cnxcy, createdTime=Tue Nov 02 12:09:59 CST 2021, time=2021-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1317665, encodeId=4a6b131e6658c, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6704, encryptionId=74916e0414, topicName=EMA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a35a460, createdName=fengyi812, createdTime=Tue Nov 02 12:09:59 CST 2021, time=2021-11-02, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=1929075, encodeId=501919290e567, content=<a href='/topic/show?id=23871020105f' target=_blank style='color:#2F92EE;'>#骨髓衰竭#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102010, encryptionId=23871020105f, topicName=骨髓衰竭)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a885259, createdName=yourmama, createdTime=Sat Mar 26 21:09:59 CST 2022, time=2022-03-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2008537, encodeId=cb03200853ed9, content=<a href='/topic/show?id=1066844469' target=_blank style='color:#2F92EE;'>#HAE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8444, encryptionId=1066844469, topicName=HAE)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=32d177, createdName=changfy, createdTime=Sat Feb 26 17:09:59 CST 2022, time=2022-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2035915, encodeId=39242035915c0, content=<a href='/topic/show?id=575c1e341a8' target=_blank style='color:#2F92EE;'>#TGF#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17341, encryptionId=575c1e341a8, topicName=TGF)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=56ea361, createdName=changhe713, createdTime=Wed Nov 03 05:09:59 CST 2021, time=2021-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2035820, encodeId=054c203582021, content=<a href='/topic/show?id=3b891e356fc' target=_blank style='color:#2F92EE;'>#TGFβ#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17356, encryptionId=3b891e356fc, topicName=TGFβ)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=467c360, createdName=yuanming7, createdTime=Tue Nov 23 09:09:59 CST 2021, time=2021-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1280255, encodeId=91f21280255df, content=<a href='/topic/show?id=2bbe289846f' target=_blank style='color:#2F92EE;'>#免疫反应#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28984, encryptionId=2bbe289846f, topicName=免疫反应)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=827b160, createdName=cnxcy, createdTime=Tue Nov 02 12:09:59 CST 2021, time=2021-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1317665, encodeId=4a6b131e6658c, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6704, encryptionId=74916e0414, topicName=EMA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a35a460, createdName=fengyi812, createdTime=Tue Nov 02 12:09:59 CST 2021, time=2021-11-02, status=1, ipAttribution=)]
    2021-11-02 fengyi812

相关资讯

Blood:基因突变导致了骨髓衰竭对骨髓移植的无应答

研究者报到了来自三个无关家庭的5位已经进展到三系骨髓衰竭的严重血小板减少症患者的治疗情况,并发表在最新一期的Blood杂志上。

Blood:遗传性骨髓衰竭患者中发现的胚系突变。

儿童和年轻人患骨髓衰竭(BMF),常怀疑是遗传性的,但在很多病例中仍不能明确诊断。Olivier Bluteau等人对一个包含来自173个家庭的179名BMF患者的队列进行研究,队列中的患者均怀疑是遗传性的,但经过医疗评估和Fanconi贫血排除后,仍不能确诊。所有患者都表现为血细胞减少,且其中12.0%的患者骨髓幼稚细胞≥5%。进行遗传评估的中位年龄是11岁;20.7%的患者不超过2岁,36.9

Blood:巨噬细胞TNF-α纵容供体T细胞合成IFN-γ促进骨髓衰竭

中心点:宿主巨噬细胞来源的TNF-α和供体T细胞上表达的TNF-αR在小鼠免疫介导的骨髓(BM)衰竭的病理机制中发挥重要作用。再生障碍性贫血(AA)患者BM中合成TNF-α的CD16+CD68+巨噬细胞的量要高于健康供体的。摘要:一直以来都认为干扰素-γ(IFN-γ)和肿瘤坏死因子-α(TNF-α)参与再生障碍性贫血和其他骨髓衰竭综合征的免疫病理生理,但具体机制尚未完全明确。近期,有研究人员在小鼠

Blood:Ripk1介导的骨髓坏死增强导致骨髓发育不良和骨髓衰竭

中心点:无限制的骨髓坏死可促进炎性细胞因子的产生,破坏HSPC功能。程序性细胞死亡中的促凋亡蛋白的新功能将造血坏死与骨髓衰竭联系起来。摘要:造血是需要平衡细胞分裂、分化和死亡的动态系统。程序性细胞死亡(PCD)的两种主要模式——凋亡和坏死,具有相同的分子机制,但结果不同,对微环境具有重要意义:凋亡细胞通过免疫沉默过程被清除,而坏死细胞内容物外泄,可引发炎症。考虑到细胞因子对造血细胞存活和分化的重要

拓展阅读

Blood:Ripk1介导的骨髓坏死增强导致骨髓发育不良和骨髓衰竭

中心点:无限制的骨髓坏死可促进炎性细胞因子的产生,破坏HSPC功能。程序性细胞死亡中的促凋亡蛋白的新功能将造血坏死与骨髓衰竭联系起来。摘要:造血是需要平衡细胞分裂、分化和死亡的动态系统。程序性细胞死亡(PCD)的两种主要模式——凋亡和坏死,具有相同的分子机制,但结果不同,对微环境具有重要意义:凋亡细胞通过免疫沉默过程被清除,而坏死细胞内容物外泄,可引发炎症。考虑到细胞因子对造血细胞存活和分化的重要

Blood:巨噬细胞TNF-α纵容供体T细胞合成IFN-γ促进骨髓衰竭

中心点:宿主巨噬细胞来源的TNF-α和供体T细胞上表达的TNF-αR在小鼠免疫介导的骨髓(BM)衰竭的病理机制中发挥重要作用。再生障碍性贫血(AA)患者BM中合成TNF-α的CD16+CD68+巨噬细胞的量要高于健康供体的。摘要:一直以来都认为干扰素-γ(IFN-γ)和肿瘤坏死因子-α(TNF-α)参与再生障碍性贫血和其他骨髓衰竭综合征的免疫病理生理,但具体机制尚未完全明确。近期,有研究人员在小鼠

Blood:遗传性骨髓衰竭患者中发现的胚系突变。

儿童和年轻人患骨髓衰竭(BMF),常怀疑是遗传性的,但在很多病例中仍不能明确诊断。Olivier Bluteau等人对一个包含来自173个家庭的179名BMF患者的队列进行研究,队列中的患者均怀疑是遗传性的,但经过医疗评估和Fanconi贫血排除后,仍不能确诊。所有患者都表现为血细胞减少,且其中12.0%的患者骨髓幼稚细胞≥5%。进行遗传评估的中位年龄是11岁;20.7%的患者不超过2岁,36.9

Blood:基因突变导致了骨髓衰竭对骨髓移植的无应答

研究者报到了来自三个无关家庭的5位已经进展到三系骨髓衰竭的严重血小板减少症患者的治疗情况,并发表在最新一期的Blood杂志上。